Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Clinical trial NCT00343356 · COMPLETED

Trial details

NCT number: NCT00343356
Sponsor: LanZhou University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Neoplasms

Start date: 1996-06-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.